Oxymap is rated 3 out of 5 in the category hospital & health care. Read and write reviews about Oxymap. Oxymap develops innovative medical devices and software for ophthalmology. The Oxymap T1 measures relative retinal vessel oxygen saturation and vessel width. It allows metabolic and structural imaging of the retina and evaluation of the pathophysiology of common eye diseases such as retinal vascular occlusions, diabetic retinopathy, age-related macular degeneration and glaucoma.
Company size
1-10 employees
Headquarters
Reykjavik, Capital Region